{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:46:11Z","timestamp":1793108771411,"version":"4.5.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.24163","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T16:16:20Z","timestamp":1659024980000},"page":"e2224163","source":"Crossref","is-referenced-by-count":57,"title":["Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia"],"prefix":"10.1001","volume":"5","author":[{"given":"Yue","family":"Wei","sequence":"first","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent K. C.","family":"Yan","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"},{"name":"Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Castle","sequence":"additional","affiliation":[{"name":"Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Gao","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine S. L.","family":"Chui","sequence":"additional","affiliation":[{"name":"Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"},{"name":"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K. C.","family":"Man","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"},{"name":"Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"Research Department of Practice and Policy, University College London School of Pharmacy, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Chung","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China"},{"name":"State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China"},{"name":"Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong SAR, China"},{"name":"The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"issue":"2","key":"zoi220682r1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jamapsychiatry.2019.3360","article-title":"Schizophrenia\u2014an overview.","volume":"77","author":"McCutcheon","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"zoi220682r3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.","volume":"353","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi220682r4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/oxfordjournals.schbul.a007076","article-title":"Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.","volume":"30","author":"Valenstein","year":"2004","journal-title":"Schizophr Bull"},{"issue":"1","key":"zoi220682r5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40263-020-00779-5","article-title":"Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview.","volume":"35","author":"Correll","year":"2021","journal-title":"CNS Drugs"},{"issue":"4","key":"zoi220682r6","doi-asserted-by":"publisher","DOI":"10.1111\/appy.v12.4","article-title":"Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region.","volume":"12","author":"Tang","year":"2020","journal-title":"Asia Pac Psychiatry"},{"issue":"9","key":"zoi220682r7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMoa1005987","article-title":"Long-acting risperidone and oral antipsychotics in unstable schizophrenia.","volume":"364","author":"Rosenheck","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi220682r8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2020.2076","article-title":"Effect of long-acting injectable antipsychotics vs usual care on time to first hospitalization in early-phase schizophrenia: a randomized clinical trial.","volume":"77","author":"Kane","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"zoi220682r9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamapsychiatry.2015.0270","article-title":"Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia: a randomized clinical trial.","volume":"72","author":"Subotnik","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"zoi220682r10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/wps.v19.1","article-title":"20-Year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"issue":"7","key":"zoi220682r11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia.","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"zoi220682r12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/ijnp\/pyz035","article-title":"Time to rehospitalization in patients with schizophrenia receiving long-acting injectable antipsychotics or oral antipsychotics.","volume":"22","author":"Lin","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"zoi220682r13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060823","article-title":"Differences in the effectiveness of long-acting injection and orally administered antipsychotics in reducing rehospitalization among patients with schizophrenia receiving home care services.","volume":"8","author":"Hsu","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"zoi220682r14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jfma.2013.01.004","article-title":"Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia\u2014a 3-year follow-up.","volume":"114","author":"Liu","year":"2015","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"zoi220682r15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/pcn.2015.69.issue-8","article-title":"Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: a retrospective cohort study.","volume":"69","author":"Chan","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"zoi220682r16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/JCP.0b013e3182a6a142","article-title":"Long-acting injectables and risk for rehospitalization among patients with schizophrenia in the home care program in Taiwan.","volume":"34","author":"Ju","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"zoi220682r17","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1176\/appi.ps.201200506","article-title":"Antipsychotic formulation and one-year rehospitalization of schizophrenia patients: a population-based cohort study.","volume":"64","author":"Huang","year":"2013","journal-title":"Psychiatr Serv"},{"key":"zoi220682r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12991-019-0254-2","article-title":"Real-world effectiveness of long-acting injections for reducing recurrent hospitalizations in patients with schizophrenia.","volume":"19","author":"Kim","year":"2020","journal-title":"Ann Gen Psychiatry"},{"issue":"6","key":"zoi220682r19","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1111\/eip.v15.6","article-title":"Clinical effectiveness of early treatment with paliperidone palmitate in schizophrenia: a retrospective real-world study in South Korea.","volume":"15","author":"Shin","year":"2021","journal-title":"Early Interv Psychiatry"},{"key":"zoi220682r20","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2020.18.2.303","author":"Lee","year":"2020","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"5","key":"zoi220682r21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8810","article-title":"Comparison of long-acting injectable antipsychotics with oral antipsychotics and suicide and all-cause mortality in patients with newly diagnosed schizophrenia.","volume":"4","author":"Huang","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi220682r22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40263-021-00809-w","article-title":"Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study.","volume":"35","author":"Bertolini","year":"2021","journal-title":"CNS Drugs"},{"issue":"2","key":"zoi220682r23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00023210-200013020-00004","article-title":"Schizophrenia in the elderly: guidelines for management.","volume":"13","author":"Sajatovic","year":"2000","journal-title":"CNS Drugs"},{"issue":"8","key":"zoi220682r24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/jpm.2008.15.issue-8","article-title":"Risk profiles for non-adherence to antipsychotic medications.","volume":"15","author":"McCann","year":"2008","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"zoi220682r25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.808002","article-title":"Long-acting injectable antipsychotic treatment in schizophrenia and co-occurring substance use disorders: a systematic review.","volume":"12","author":"Coles","year":"2021","journal-title":"Front Psychiatry"},{"issue":"2","key":"zoi220682r26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1192\/apt.bp.114.013565","article-title":"Why are long-acting injectable antipsychotics still underused?","volume":"21","author":"Bosanac","year":"2015","journal-title":"BJPsych Adv"},{"issue":"6","key":"zoi220682r28","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1001\/jamainternmed.2016.1586","article-title":"Association between acute neuropsychiatric events and Helicobacter pylori therapy containing clarithromycin.","volume":"176","author":"Wong","year":"2016","journal-title":"JAMA Intern Med"},{"key":"zoi220682r29","doi-asserted-by":"publisher","first-page":"j2350","DOI":"10.1136\/bmj.j2350","article-title":"Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study.","volume":"357","author":"Man","year":"2017","journal-title":"BMJ"},{"issue":"10","key":"zoi220682r30","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamainternmed.2021.4571","article-title":"Association between prenatal exposure to antipsychotics and attention-deficit\/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age.","volume":"181","author":"Wang","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"10","key":"zoi220682r31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamapsychiatry.2017.2183","article-title":"Association of risk of suicide attempts with methylphenidate treatment.","volume":"74","author":"Man","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"zoi220682r32","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.216","article-title":"Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.","volume":"6","author":"Man","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"6","key":"zoi220682r33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2352-4642(20)30100-0","article-title":"Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study.","volume":"4","author":"Man","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"zoi220682r36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi220682r37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jagp.2019.08.005","article-title":"A comparison of long-acting injectable antipsychotics with oral antipsychotics on time to rehospitalization within 1 year of discharge in elderly patients with schizophrenia.","volume":"28","author":"Lin","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"zoi220682r38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/appy.2016.8.issue-2","article-title":"Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.","volume":"8","author":"Lo","year":"2016","journal-title":"Asia Pac Psychiatry"},{"key":"zoi220682r34","doi-asserted-by":"crossref","DOI":"10.1201\/9780429491313","volume-title":"Self-controlled Case Series Studies: A Modelling Guide With R","author":"Farrington","year":"2018"},{"key":"zoi220682r35"},{"key":"zoi220682r2","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD 2019 cause and risk summary: schizophrenia\u2014level 3 cause. Accessed June 25, 2022. https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/schizophrenia-level-3-cause"},{"key":"zoi220682r27","unstructured":"Hong Kong Hospital Authority. Hospital Authority introduction. Accessed September 30, 2020. https:\/\/www.ha.org.hk\/visitor\/ha_index.asp"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2794734\/wei_2022_oi_220682_1658348592.89483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T16:16:25Z","timestamp":1659024985000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2794734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.24163","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]}}}